Novavax

NVAXNASDAQ
$11.84
-0.71-5.66%
Last update: 3:24 PM
15 minutes delayed

Novavax (NASDAQ:NVAX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
05/10/2024NVAX
Novavax
FY2024———$400.00M$600.00M$845.49MGet Alert
02/28/2024NVAX
Novavax
Q12024———$100.00M$100.00M$292.33MGet Alert
02/28/2024NVAX
Novavax
FY2024———$800.00M$1.00B$969.56MGet Alert
11/09/2023NVAX
Novavax
FY2023———$900.00M$1.10B$1.35BGet Alert
11/09/2023NVAX
Novavax
Q12024———$300.00M$300.00M$648.29MGet Alert
08/08/2023NVAX
Novavax
FY2023———$1.30B$1.50B$1.44BGet Alert
05/09/2023NVAX
Novavax
FY2023———$1.40B$1.60B$831.60MGet Alert
12/14/2022NVAX
Novavax
FY2022———$2.00B$2.00B$2.01BGet Alert
11/08/2022NVAX
Novavax
FY2022———$2.00B$2.00B$2.04BGet Alert
08/08/2022NVAX
Novavax
FY2022———$2.00B$2.30B$4.27BGet Alert
05/09/2022NVAX
Novavax
FY2022———$4.00B$5.00B$4.49BGet Alert
02/28/2022NVAX
Novavax
FY2022———$4.00B$5.00B$4.70BGet Alert

FAQ

Q

What is the most recent guidance for Novavax (NVAX)?

A

There have been no specific sales or earnings guidance reported for Novavax in recent months.

Browse guidance and forecast on all stocks.

People Also Watch